Page 7 - Junshi Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJunshi biosciencesYuelei shenHansoh pharmaHaimen jiangsuChipscreen newway biosciencesDevelopment businessMerck kgaMerck kgaaBiocytogen pharmaceuticals beijing co ltdEco development businessProject integrumRona therapeuticsFully humanPlatform licensing business

Biocytogen Launches RenBiologics A SubBrand Focused on OutLicensing Fully Human Antibodies For Therapeutic Development

Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 today announced the launch of a new subbrand RenBiologics to represent the companys antibody discovery business division.

San franciscoUnited statesHansoh pharmaJunshi biosciencesHaimen jiangsuYuelei shenChipscreen newway biosciencesMerck kgaDevelopment businessBiocytogen pharmaceuticals beijing co ltdMerck kgaaEco development businessProject integrumRona therapeuticsFully humanPlatform licensing business

1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study

In this population based cohort study of >37,000 people in Hong Kong, Hongjiang Wu and colleagues examine 1-year weight change after diabetes diagnosis with long-term incidence and sustainability of diabetes remission.

Hong kongUniversity of hong kongHong kong generalEli lillyMerck seronoJunshi biosciencesAstra zenecaDaiichi sankyoHospital authorityTricida incManagement programme for diabetes mellitusInternational consensusHong kong hospital authorityNovo nordiskChinese university of hong kongBoehringer ingelheim

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development

BEIJING Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced the launch of a new sub-brand, RenBiologics

United statesNew yorkSan franciscoChipscreen newway biosciencesBarbara shecterJunshi biosciencesGabriel friedmanHansoh pharmaJoe oconnorHaimen jiangsuYuelei shenJoe oliverNational postBiocytogen pharmaceuticals beijing co ltdMerck kgaCanada revenue agency

Sandoz buys Coherus Lucentis biosimilar Cimerli for $170M

Sandoz buys Coherus Lucentis biosimilar Cimerli for $170M
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Redwood cityUnited statesRoche lucentisCoherus biosciencesKeren haruviDenny lanfearJunshi biosciencesNorth america